Last reviewed · How we verify
NCT07346911: DigiTIFF
Digital Interventions for Relapse Prevention in Adolescence
NA trial testing Transdiagnostic app intervention in Major Depression Disorder in 495 participants. Not yet recruiting.
1 June 2027
Quick facts
| Lead sponsor | University of Oslo |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 495 |
| Start date | 7 April 2026 |
| Primary completion | 1 June 2027 |
| Estimated completion | 1 June 2027 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Transdiagnostic app intervention
- Transdiagnostic mastery course
Conditions studied
- Major Depression Disorder — all drugs for Major Depression Disorder →
- ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) — all drugs for ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) →
Sponsor
University of Oslo
Who can join
Adults 16 to 19, any sex, with Major Depression Disorder or ANXIETY DISORDERS (or Anxiety and Phobic Neuroses). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Some adolescents experience periods of anxiety and/or depression, and some find that these periods return over time. The purpose of this study is to examine whether digital interventions-where individuals work systematically with their own thoughts and feelings during periods when they feel well-can help them maintain well-being for longer. The study includes adolescents aged 16-19 who have previously experienced episodes of depression and/or anxiety to a degree that led them to seek help (e.g., from a school nurse, general practitioner, health clinic, or child and adolescent mental health service). Through a research app on their smartphones, participants complete tasks and answer questionnaires. The study is fully digital. Some participants meet with a therapist in digital group sessions, while others work independently with the digital content. We will also examine the cost-benefit aspects of offering such interventions. If the study achieves its goals, digital interventions may eventually become a service offered to adolescents recovering from depression and anxiety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07346911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Major Depression Disorder
Currently open trials in the same condition.
- NCT07039370 — Molecular Signatures of TMS Response in Treatment-Resistant Depression · NA · recruiting
- NCT06671977 — Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans · Phase 1 · recruiting
- NCT07111169 — Neuromodulation and Attention Deficits in MDD · NA · recruiting
Other University of Oslo trials
Trials by the same sponsor.
- NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
- NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
- NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
- NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting
- NCT07312435 — B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07346911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oslo
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07346911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing